Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 60 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 8883448

    Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  2. US 8877199

    B cell surface reactive antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  3. US 8877914

    Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  4. US 8877213

    Live attenuated Leishmania vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  5. US 8877765

    Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  6. US 8871789

    Method of preventing or treating viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  7. US 8871902

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  8. US 8871906

    Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  9. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  10. US 8871191

    Use of IL-15 preparations to treat lymphopenia

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  11. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  12. US 8865880

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  13. US 8865461

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  14. US 8865672

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  15. US 8858930

    Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  16. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  17. US 8859207

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  18. US 8858959

    Gel vaccine delivery system for treating poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  19. US 8859585

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  20. US 8858946

    Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  21. US 8852598

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  22. US 8853277

    Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  23. US 8852605

    Vibrio cholerae O139 conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  24. US 8853160

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.